Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC Published 2023-02-16 Download video MP4 360p Download video MP4 720p Recommendations 2:16:45 Immuno-Oncology Symposium - Part 1 1:01:14 Early stage lung cancer - advances in diagnosis and management (29 November 2022) 36:26 Preoperative Evaluation - (Dr. Hessel) 39:06 Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC 48:33 Introduction to Cancer 04:44 Understanding Non-Small Cell Lung Cancer 06:20 ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trial 55:38 New Advances in Research & Treatment in Ovarian Cancer 58:15 Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022) 42:55 EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know 2:45:20 287 ‒ Lower back pain: causes, treatment, and prevention of lower back injuries and pain 01:58 BILIRUBIN 1:00:39 AO Trauma Fellows NA Webinar—Acetabulum: ABCs, Ts, ACPHTs Oh My 1:20:02 HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 41:58 Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLC 16:28 PERIOPERATIVE NURSING (PRE-OP) 03:46 Understanding Immunotherapy for Lung Cancer 33:39 Transcranial Magnetic Stimulation: A New Treatment Approach for Psychiatric Disorders 36:58 What You Need to Know about Non-Hodgkin's Lymphoma: Presentation Similar videos 53:19 Improving Survival and Cure Rates in Resectable NSCLC With Perioperative Immunotherapy 49:11 How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC 1:27:28 The Continuing Success Story of Immunotherapy in NSCLC 41:23 Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings 43:35 Maximizing the Impact of EGFR-Targeted Therapy in Resectable NSCLC 1:08:00 Has Immunotherapy Brought Us to an Inflection Point in the Management of Stage I-III NSCLC? 18:24 ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology Brothers 1:03:09 Drs. Altorki & Spicer discuss #NSCLC at #STS2023 - https://bit.ly/3wi057L 1:10:20 Watch Drs Broderick & Wakelee discuss the latest in NSCLC: https://bit.ly/2021-NSCLC 1:11:16 Immunotherapy as a Game-Changer in Multimodal Management of Lung Cancer 33:39 Local Lung Cancer | 2022 OneOncology Conference 56:08 Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies 32:12 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Front Line Therapy 1:18:32 Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations 1:01:22 June 28th Lung Cancer Webinar - Post ASCO Review 29:46 Lung Cancer and Immunotherapy with Dr. Patrick Forde and Oswald Peterson More results